Viewing Study NCT00633802


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-06-17 @ 7:36 PM
Study NCT ID: NCT00633802
Status: UNKNOWN
Last Update Posted: 2008-03-12
First Post: 2008-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: 04-089
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Miki Bloch
Old Organization: Tel-Aviv Sourasky Medical Center

Collaborators